298C Ertel, Adam - Thomas Jefferson University - Thomas Jefferson University
ame004

Adam Ertel, PhD

Contact Dr. Ertel

Kimmel Cancer Center
233 S. Tenth Street, Suite 1009
Philadelphia, PA 19107

(215) 503-7452
(215) 503-9142 fax

Most Recent Peer-reviewed Publications

  1. Structure-based screen identifies a potent small molecule inhibitor of Stat5a/b with therapeutic potential for prostate cancer and chronic myeloid leukemia
  2. The endogenous cell-fate factor dachshund restrains prostate epithelial cell migration via repression of cytokine secretion via a CXCL signaling module
  3. Kinase-independent role of cyclin D1 in chromosomal instability and mammary tumorigenesis
  4. RB loss contributes to aggressive tumor phenotypes in MYC-driven triple negative breast cancer
  5. Monocyte-macrophage differentiation of acute myeloid leukemia cell lines by small molecules identified through interrogation of the connectivity map database
  6. A community effort to assess and improve drug sensitivity prediction algorithms
  7. A community computational challenge to predict the activity of pairs of compounds
  8. CCR5 receptor antagonists block metastasis to bone of v-Src oncogene-transformed metastatic prostate cancer cell lines
  9. The retinoblastoma tumor suppressor modulates DNA repair and radioresponsiveness
  10. Retinoblastoma protein potentiates the innate immune response in hepatocytes: Significance for hepatocellular carcinoma
  11. The retinoblastoma tumor suppressor pathway modulates the invasiveness of ErbB2-positive breast cancer
  12. Cell fate factor DACH1 represses YB-1-mediated oncogenic transcription and translation
  13. Identification of a cyclin D1 network in prostate cancer that antagonizes epithelial-mesenchymal restraint
  14. Retinoblastoma protein potentiates the innate immune response in hepatocytes: Significance for hepatocellular carcinoma
  15. Functional significance of macrophage-derived exosomes in inflammation and pain
  16. Cyclin D1 induction of dicer governs microRNA processing and expression in breast cancer
  17. Cancer cell proliferation through cyclin D1
  18. Global profiling of prolactin-modulated transcripts in breast cancer in vivo
  19. STAT5A/B gene locus undergoes amplification during human prostate cancer progression
  20. Acetylation of the cell-fate factor dachshund determines p53 binding and signaling modules in breast cancer
0